Michael J. Reardon, MD: Long-Term TAVR Plans

Michael J. Reardon, MD: Long-Term TAVR Plans

Low Risk TAVR: What the Data Tells Us (Michael J. Reardon, MD) March 26, 2020Подробнее

Low Risk TAVR: What the Data Tells Us (Michael J. Reardon, MD) March 26, 2020

TAVR: Optimizing the Choice of Prosthesis and Patient (MICHAEL J. REARDON, MD)Подробнее

TAVR: Optimizing the Choice of Prosthesis and Patient (MICHAEL J. REARDON, MD)

TAVR and Valve-in-Valve (Michael Reardon, MD)Подробнее

TAVR and Valve-in-Valve (Michael Reardon, MD)

TAVR is an All Comers Therapy - Michael Reardon, MDПодробнее

TAVR is an All Comers Therapy - Michael Reardon, MD

TAVR Horizons: Partner II, SurTAVI and Beyond (Michael J. Reardon, MD) April 30, 2016Подробнее

TAVR Horizons: Partner II, SurTAVI and Beyond (Michael J. Reardon, MD) April 30, 2016

TAVR-Device Selection & Expanding Indications/Percutaneous Alt. Access (Michael J. Reardon, MD)Подробнее

TAVR-Device Selection & Expanding Indications/Percutaneous Alt. Access (Michael J. Reardon, MD)

How I Teach TAVR (Ross M. Reul, MD, and Michael J. Reardon, MD)Подробнее

How I Teach TAVR (Ross M. Reul, MD, and Michael J. Reardon, MD)

Transcatheter Aortic Valve Replacement: Will Surgical AVR Disappear? (Michael Reardon, MD)Подробнее

Transcatheter Aortic Valve Replacement: Will Surgical AVR Disappear? (Michael Reardon, MD)

Michael J. Reardon, MD: The TAVR Study for Low-Risk MortalityПодробнее

Michael J. Reardon, MD: The TAVR Study for Low-Risk Mortality

Michael J Reardon, MD - TAVR in Asymptomatic or Moderate ASПодробнее

Michael J Reardon, MD - TAVR in Asymptomatic or Moderate AS

TMVR - Hope or Hype (Michael J. Reardon, MD)Подробнее

TMVR - Hope or Hype (Michael J. Reardon, MD)

Disruptive Innovation: TAVR 20 Years Later | April 4Подробнее

Disruptive Innovation: TAVR 20 Years Later | April 4

TAVR Data for the Surgeon (Michael Reardon, MD)Подробнее

TAVR Data for the Surgeon (Michael Reardon, MD)

Cerebral Embolization During Protected TAVR(Lumsden MD, Reardon MD, Kleiman MD, Sinha MD, Garami MD)Подробнее

Cerebral Embolization During Protected TAVR(Lumsden MD, Reardon MD, Kleiman MD, Sinha MD, Garami MD)

TAVR (Michael J. Reardon, MD) - April 6th, 2017 Re-Evolution SummitПодробнее

TAVR (Michael J. Reardon, MD) - April 6th, 2017 Re-Evolution Summit

Which Low-Risk Patients Should Receive TAVR?Подробнее

Which Low-Risk Patients Should Receive TAVR?

Self-Expanding Transcatheter or Surgical AVR in severe AS Pts at Low Surgical RiskПодробнее

Self-Expanding Transcatheter or Surgical AVR in severe AS Pts at Low Surgical Risk

Michael J Reardon, MD on durability of TAVR in patients with aortic stenosis with Chadi Alraies, MDПодробнее

Michael J Reardon, MD on durability of TAVR in patients with aortic stenosis with Chadi Alraies, MD

The Treatment of Aortic Valve Disease in 2020, A Surgeon’s Perspective (Michael J. Reardon, MD)Подробнее

The Treatment of Aortic Valve Disease in 2020, A Surgeon’s Perspective (Michael J. Reardon, MD)

TAVR Valves That Are Here and Valves That Are Coming (Michael Reardon, MD)Подробнее

TAVR Valves That Are Here and Valves That Are Coming (Michael Reardon, MD)